All Stories

  1. Scrutinized with inadequate control and support: Interns' experiences communicating with and writing referrals to hospital radiology departments – A qualitative study
  2. COBRA: A prospective multimodal imaging study of dopamine, brain structure and function, and cognition
  3. ICRP Publication 128: Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances
  4. PO-0958: Correlations between DCE-MRI, [18F]-FLT PET and survival in patients with high grade glioma
  5. Evaluation of inter-departmental variability of ejection fraction and cardiac volumes in myocardial perfusion scintigraphy using simulated data
  6. The accuracy of quantitative parameters in99mTc-MAG3 dynamic renography: a national audit based on virtual image data
  7. 11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study
  8. Dopamine release in nucleus accumbens during rewarded task switching measured by [11C]raclopride
  9. Accuracy of Visual Assessment of Dopamine Transporter Imaging in Early Parkinsonism
  10. Genome wide expression analysis of radiation-induced DNA damage responses in isogenic HCT116 p53+/+ and HCT116 p53−/− colorectal carcinoma cell lines
  11. The Role of Imaging Specialists as Authors of Systematic Reviews on Diagnostic and Interventional Imaging and Its Impact on Scientific Quality: Report from the EuroAIM Evidence-based Radiology Working Group
  12. Durable stabilization of three chordoma cases by bevacizumab and erlotinib
  13. 123I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools
  14. Cross-camera comparison of ROI-based semi-quantitative 123I-IBZM SPECT data in healthy volunteers using an anthropomorphic phantom for calibration
  15. Subcentimeter Tumor Lesion Delineation for High-Resolution 18F-FDG PET Images: Optimizing Correction for Partial-Volume Effects
  16. The Role of Imaging in Nuclear Medicine: The Medical Perspective
  17. Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
  18. Rotation Radius Dependence of 123I-FP-CIT and 123I-IBZM SPECT Uptake Ratios: A Monte Carlo Study
  19. Reducing scanning time to 50% for 111In pentetreotide SPECT when using model-based compensation
  20. Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma
  21. Evaluation of an attenuation correction method for PET/MR imaging of the head based on substitute CT images
  22. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study
  23. Memory aging and brain maintenance
  24. Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis
  25. 927 Sentinel node detection in renal cell carcinoma. A feasibility study
  26. Current activities in the ICRP concerning estimation of radiation doses to patients from radiopharmaceuticals for diagnostic use
  27. Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes
  28. Association of adipose tissue blood flow with fat depot sizes and adipokines in women
  29. 1H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples
  30. Influences of Age and Length of Education on rCBF-SPECT in Healthy Elderly: Diagnostic Implications for Dementia
  31. Detection of Local Prostate Metabolites by HRMAs NMR Spectroscopy: A Comparative Study of Human and Rat Prostate Tissues
  32. Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study
  33. Dopamine D2 receptor SPECT with 123 I-IBZM: evaluation of collimator and post-filtering when using model-based compensation—a Monte Carlo study
  34. PET/CT: nuclear medicine imaging in the future
  35. Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy
  36. Striatal dopamine D2 binding is related to frontal BOLD response during updating of long-term memory representations
  37. Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson’s disease in a population-based cohort
  38. Iodine-131 induces Mitotic Catastrophes and Activates Apoptotic Pathways in HeLa Hep2 Cells
  39. Iodine-131 Induces Mitotic Catastrophes and Activates Apoptotic Pathways in HeLa Hep2 Cells
  40. Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory
  41. Radiation Induced Cell Deaths
  42. Therapeutically Used Targeted Antigens in Radioimmunotherapy
  43. Targeting Tumours with Radiolabeled Antibodies
  44. Radiation Induced DNA Damage Checkpoints
  45. Cancer Stem Cells and Radiation
  46. Cell Cycle Disturbances and Mitotic Catastrophes in HeLa Hep2 Cells following 2.5 to 10 Gy of Ionizing Radiation
  47. Gaussian prefiltering of 123 I DAT SPECT images when using depth-independent resolution recovery
  48. Ultrasound, computed tomography, and laboratory findings in the diagnosis of appendicitis
  49. Tumor Radioimmunolocalization in Nude Mice by Mono- and Divalent- Single-Chain Fv Antiplacental Alkaline Phosphatase Antibodies
  50. 1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning
  51. Correction for scatter and septal penetration using convolution subtraction methods and model-based compensation in 123 I brain SPECT imaging—a Monte Carlo study
  52. Construction and Purification of a Covalently Linked Divalent Tandem Single-Chain Fv Antibody Against Placental Alkaline Phosphatase
  53. Optimizing the Generation of Recombinant Single-Chain Antibodies Against Placental Alkaline Phosphatase
  54. Altered cerebral blood flow in chronic neck pain patients but not in whiplash patients: a 99mTc-HMPAO rCBF study
  55. In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives
  56. Treatment of chronic stress in employees: Subjective, cognitive and neural correlates
  57. Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer’s disease?
  58. Visual consciousness: Dissociating the neural correlates of perceptual transitions from sustained perception with fMRI
  59. Positive pivot shift after ACL reconstruction predicts later osteoarthrosis63 patients followed 5–9 years after surgery
  60. Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours
  61. A method for attenuation and scatter correction of brain SPECT based on computed tomography images
  62. Effects of interferon-α, verapamil and dacarbazine in the treatment of advanced malignant melanoma
  63. Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met)
  64. MRI of the Skeleton in Prostate Cancer Staging
  65. Apoptosis in HeLa Hep2 Cells is Induced by Low-Dose, Low-Dose-Rate Radiation
  66. Memory functions and rCBF 99mTc-HMPAO SPET: developing diagnostics in Alzheimer's disease
  67. The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody
  68. Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): a dosimetric evaluation
  69. Quantitative bone scintigraphy: A methodological evaluation in prostate cancer
  70. QUANTITATIVE BONE SCINTIGRAPHY. A methodological evaluation in prostate cancer
  71. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation
  72. Experimental radioimmunotargeting combining nonlabeled, iodine‐125‐labeled, and anti‐idiotypic anticytokeratin monoclonal antibodies
  73. Radioimmunoscintigraphy with a novel monoclonal antiprostate antibody (E4)
  74. Dosimetry of fractionated administration of125I-labeled antibody at experimental radioimmunotargeting
  75. Endogenous anti-tumor antibody responses in nude mice
  76. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti‐idiotypic anticytokeratin antibodies
  77. Dosimetry of fractionated administration of 125I‐labeled antibody at experimental radioimmunotargeting
  78. Endogenous anti‐tumor antibody responses in nude mice
  79. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies
  80. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies
  81. Radioimmunoscintigraphy with a novel monoclonal antiprostate antibody (E4)
  82. Combinations of nonlabeled, 125I-Labeled, and Anti-Idiotypic Antiplacental Alkaline Phosphatase Monoclonal Antibodies at Experimental Radioimmunotargeting
  83. Combinations of nonlabeled, 125I-Labeled, and Anti-Idiotypic Antiplacental Alkaline Phosphatase Monoclonal Antibodies at Experimental Radioimmunotargeting
  84. Twenty Years with Monoclonal Antibodies: State of the art-Where do we go?
  85. Secondary Antibodies as Tools to Improve Tumor to Non Tumor Ratio at Radioimmunolocalisation and Radioimmunotherapy
  86. A Putative Mechanism for the Non-Specific Uptake of Intact Radiolabelled Monoclonal Antibodies in the Testes and Prostate
  87. Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization
  88. In vivo and in vitro interactions between idiotypic and antiidiotypic monoclonal antibodies against placental alkaline phosphatase
  89. ANTHDIOTYPIC ANTIBODIES AGAINST RADIOLABELLED MONOCLONAL ANTIBODIES IMPROVE RADIOIMMUNOLOCALIZATION AND RADIOIMMUNOTHERAPY
  90. Radioimmunodetection of Ovarian Cancer
  91. Alternative Technologies to Generate Monoclonal Antibodies
  92. Radioimmunoscintigraphy of Gynecologic Tumors with 131I-Labeled Anti-Plap Monoclonal Antibodies
  93. Radioimmunoscintigraphy of Gynecologic Tumors with131I-Labeled Anti-Plap Monoclonal Antibodies
  94. Tumour Radioimmunolocalization in Nude Mice by Use of Antiplacental Alkaline Phosphatase Monoclonal Antibodies